Genopathy
Gene-Disorder Association · Article
Gene
EGFR
Epidermal Growth Factor Receptor
Manually curated
Association Review

In brief

The association between EGFR (Epidermal Growth Factor Receptor) and Lung Cancer Susceptibility 3 is well established and manually curated, with its 2 contributing sources — 1 of them expert-curated — recording likely-pathogenic variants.

Sources 2
Clinical variants 29
Symptoms 0
Compounds 0
Trials 0
Publications 72
01
At a glance

Association overview

A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.

Request access
02
Provenance

Evidence and sources

2 sources

Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.

Request access
03
EGFR

The gene

3 source summaries

A gene summary alongside the source descriptions it was distilled from.

Request access
04
Lung Cancer Susceptibility 3

The disorder

10 database identifiers

The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).

Request access
05
ClinVar and variant evidence

Genetic basis

29 clinical variants

ClinVar variants reported for this pair, with disorder-specific significance, review status, molecular consequence and origin.

Request access
06
Mechanism overlap

Shared mechanisms

1 shared pathway

Biological pathways and phenotype concepts shared by the gene and the disorder, with supporting publications.

Request access
07
Literature

Reading

72 publications

Publications linking the gene and the disorder, with title, authors, journal, year and citation metrics.

Request access
08
Provenance

References & sources

17 references

Every source and publication cited across this dossier, as one numbered reference list.

Request access